Key facts
- This page summarizes Maria Ostrovsky's Form 4 filing for Candel Therapeutics, Inc. (CADL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Nov 2026, 16:24.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
25% of the shares underlying this option shall vest and become exercisable on November 3, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.